European Medicines Agency Doc. Ref.: EMEA[removed]

First Page		Document Content
Date: 2013-07-21 05:36:38 Electrolyte disturbances Syndromes Diuretics Amides Organochlorides Hyponatremia Syndrome of inappropriate antidiuretic hormone hypersecretion Tolvaptan Vasopressin Medicine Chemistry Health		European Medicines Agency Doc. Ref.: EMEA[removed] Add to Reading List Source URL: www.ema.europa.eu Download Document from Source Website File Size: 48,53 KB Share Document on Facebook

	Effective OctoberDay Supply Qty 90-Day Supply Qty DocID: 1row0 - View Document
	As at AugustAstraZeneca’s Environmental Risk Summaries As part of AstraZeneca’s ongoing commitment to environmental data transparency, this website provides environmental risk summaries for the Active Pharmace DocID: 1rlq4 - View Document
	^ & =» e: cr 03 (t 2 3 i-jas CD3 CL 3=11 o i ft)13 S3> 3- 3f CO p3.13 DocID: 1r5tE - View Document
	torsemide or recall, torsemide inj, furosemide torsemide conversion torsemide dosage severe congestive heart failure. side effects of torsemide, torsemide and lasix equivalent dose torsemide dosage. torsemide 100 mg. exp DocID: 1r0YX - View Document
	congestive heart failure furosemide. ic furosemide side effects, furosemide used for chronic use of furosemide side-effects, double concentrated furosemide infusion buy furosemide for livestock. furosemide dogs. side eff DocID: 1pZZ9 - View Document